Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that ...

U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

Merck is particularly exposed to the tariff threat, as much of its production of Keytruda takes place at facilities in ...

The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster ...

Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.

Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...

She regularly appears on CBS News 24/7 to discuss her reporting. Merck is investing $1 billion to build a U.S. plant in ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

Merck estimates the project will create more than 500 full-time roles and about 4,000 construction jobs. CEO of Main Line ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

To keep up with growing demand, ​​Merck Animal Health will invest nearly $900 million to expand its manufacturing facility in ...